The physiologic effects of indomethacin test on CPP and ICP in severe Traumatic Brain Injury (sTBI)

Neurocritical Care

Volumn 20, Issue 2, 2014, Pages 230-239

  Godoy, Daniel Agustín ^a,b   Alvarez, Erica ^a   Manzi, Ruben ^a   Piñero, Gustavo ^c   Di Napoli, Mario ^d,e  

^a Neurocritical Care Unit Sanatorio Pasteur   (Argentina)

^b Hospital Interzonal de Agudos San Juan Bautista   (Argentina)

^c Leonidas Lucero Municipal Hospital   (Argentina)

^d SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

^e Neurological Section   (Italy)

Author keywords

Cerebral perfusion pressure; Critical care; Head trauma; Indomethacin; Intracranial hypertension; Intracranial pressure; Traumatic brain injury

Indexed keywords

INDOMETACIN; CARDIOVASCULAR AGENT;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN PERFUSION; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; DRUG SAFETY; FEMALE; GLASGOW OUTCOME SCALE; HUMAN; INTENSIVE CARE; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; LOADING DRUG DOSE; MALE; MIDDLE AGED; MORTALITY; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; TRAUMATIC BRAIN INJURY; YOUNG ADULT; BRAIN CIRCULATION; BRAIN INJURIES; COMPLICATION; DRUG EFFECTS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BRAIN INJURIES; CARDIOVASCULAR AGENTS; CEREBROVASCULAR CIRCULATION; GLASGOW OUTCOME SCALE; HUMANS; INDOMETHACIN; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84896546439     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-013-9924-0     Document Type: Article

References (48)

1. Zammit C, Knight WA. Severe traumatic brain injury in adults. Emerg Med Pract. 2013;15:1-28.
2. Mauritz W, Wilbacher I, Majdan M, et al. Epidemiology, treatment and outcome of patients after severe traumatic brain injury in European regions with different economic status. Eur J Public Health. 2008;18:575-80.
3. Maas AI, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008;7:728-41. (Pubitemid 351957931)
4. Rutland-Brown W, Langlois JA, Thomas KE, Xi YL. Incidence of traumatic brain injury in the United States, 2003. J Head Trauma Rehabil. 2006;21:544-8. (Pubitemid 44813644)
5. Miller JD, Becker DP, Ward JD, Sullivan HG, Adams WE, Rosner MJ. Significance of intracranial hypertension in severe head injury. J Neurosurg. 1977;47:503-16. (Pubitemid 8193896)
6. Rangel-Castilla L, Gopinath S, Robertson CS. Management of intracranial hypertension. Neurol Clin. 2008;26:521-41. (Pubitemid 351734581)
7. Meyer MJ, Megyesi J, Meythaler J, et al. Acute management of acquired brain injury part I: an evidence-based review of nonpharmacological interventions. Brain Inj. 2010;24:694-705.
8. Meyer MJ, Megyesi J, Meythaler J, et al. Acute management of acquired brain injury part II: an evidence-based review of pharmacological interventions. Brain Inj. 2010;24:706-21.
9. Biestro AA, Alberti RA, Soca AE, Cancela M, Puppo CB, Borovich B. Use of indomethacin in brain-injured patients with cerebral perfusion pressure impairment: preliminary report. J Neurosurg. 1995;83:627-30.
10. Clemmesen JO, Hansen BA, Larsen FS. Indomethacin normalizes intracranial pressure in acute liver failure: a twenty-three-year-old woman treated with indomethacin. Hepatology. 1997;26:1423-5. (Pubitemid 27520006)
11. Imberti R, Fuardo M, Bellinzona G, Pagani M, Langer M. The use of indomethacin in the treatment of plateau waves: effects on cerebral perfusion and oxygenation. J Neurosurg. 2005; 102:455-9. (Pubitemid 43194036)
12. Jensen K, Ohrstrom J, Cold GE, Astrup J. The effects of indomethacin on intracranial pressure, cerebral blood flow and cerebral metabolism in patients with severe head injury and intracranial hypertension. Acta Neurochir (Wien). 1991; 108:116-21.
13. Godoy DA, Rabinstein AA, Biestro A, Ainslie PN, Di Napoli M. Effects of indomethacin test on intracranial pressure and cerebral hemodynamics in patients with refractory intracranial hypertension: a feasibility study. Neurosurgery. 2012;71:245-57 discussion 57-8.
14. Rasmussen M. Treatment of elevated intracranial pressure with indomethacin: friend or foe? Acta Anaesthesiol Scand. 2005;49: 341-50. (Pubitemid 40432528)
15. Roberts RG, Redman JW. Indomethacin: a review of its role in the management of traumatic brain injury. Crit Care Resusc. 2002;4:271-80.
16. Slavik RS, Rhoney DH. Indomethacin: a review of its cerebral blood flow effects and potential use for controlling intracranial pressure in traumatic brain injury patients. Neurol Res. 1999;21:491-9. (Pubitemid 29350433)
17. Dahl B, Bergholt B, Cold GE, et al. CO(2) and indomethacin vasoreactivity in patients with head injury. Acta Neurochir (Wien). 1996;138:265-73. (Pubitemid 26096787)
18. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2:81-4.
19. Marshall LF, Marshall SB, Klauber MR, et al. A new classification of head injury based on computerized tomography. Special Supplements. 1991;75:S14-20.
20. Foundation BT. Guidelines for the management of severe traumatic brain injury. J Neurotrauma. 2007;24:S1-106.
21. TBT Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Guidelines for cerebral perfusion pressure. J Neurotrauma. 2000;17:507-11.
22. Puppo C, Lopez L, Farina G, et al. Indomethacin and cerebral autoregulation in severe head injured patients: a transcranial Doppler study. Acta Neurochir (Wien). 2007;149:139-49 discussion 49.
23. Wilson JT, Pettigrew LE, Teasdale GM. Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma. 1998;15:573-85.
24. Jensen K, Kjaergaard S, Malte E, Bunemann L, Therkelsen K, Knudsen F. Effect of graduated intravenous and standard rectal doses of indomethacin on cerebral blood flow in healthy volunteers. J Neurosurg Anesthesiol. 1996;8:111-6. (Pubitemid 26099786)
25. Rasmussen M, Tankisi A, Cold GE. The effects of indomethacin on intracranial pressure and cerebral haemodynamics in patients undergoing craniotomy: a randomised prospective study. Anaesthesia. 2004;59:229-36. (Pubitemid 38263252)
26. Harrigan MR, Tuteja S, Neudeck BL. Indomethacin in the management of elevated intracranial pressure: a review. J Neurotrauma. 1997;14:637-50. (Pubitemid 27424267)
27. Upton RN, Rasmussen M, Grant C, Martinez AM, Cold GE, Ludbrook GL. Pharmacokinetics and pharmacodynamics of indomethacin: effects on cerebral blood flow in anaesthetized sheep. Clin Exp Pharmacol Physiol. 2008;35:317-23. (Pubitemid 351257875)
28. Eriksson S, Hagenfeldt L, Law D, Patrono C, Pinca E, Wennmalm A. Effect of prostaglandin synthesis inhibitors on basal and carbon dioxide stimulated cerebral blood flow in man. Acta Physiol Scand. 1983;117:203-11. (Pubitemid 13121034)
29. Pickard J, Tamura A, Stewart M, McGeorge A, Fitch W. Prostacyclin, indomethacin and the cerebral circulation. Brain Res. 1980;197:425-31. (Pubitemid 10040303)
30. Pickard JD, MacDonell LA, Mackenzie ET, Harper AM. Prostaglandin-induced effects in the primate cerebral circulation. Eur J Pharmacol. 1977;43:343-51. (Pubitemid 8120156)
31. Quintana A, Raczka E, Quintana MA. Effects of indomethacin and diclofenac on cerebral blood flow in hypercapnic conscious rats. Eur J Pharmacol. 1988;149:385-8.
32. Markus HS, Vallance P, Brown MM. Differential effect of three cyclooxygenase inhibitors on human cerebral blood flow velocity and carbon dioxide reactivity. Stroke. 1994;25:1760-4. (Pubitemid 24274968)
33. Weigert G, Berisha F, Resch H, Karl K, Schmetterer L, Garhofer G. Effect of unspecific inhibition of cyclooxygenase by indomethacin on retinal and choroidal blood flow. Invest Ophthalmol Vis Sci. 2008;49:1065-70.
34. Jensen K, Freundlich M, Bunemann L, Therkelsen K, Hansen H, Cold GE. The effect of indomethacin upon cerebral blood flow in healthy volunteers. The influence of moderate hypoxia and hypercapnia. Acta Neurochir (Wien). 1993;124:114-9. (Pubitemid 23329825)
35. Bruhn H, Fransson P, Frahm J. Modulation of cerebral blood oxygenation by indomethacin: MRI at rest and functional brain activation. J Magn Reson Imaging. 2001;13:325-34. (Pubitemid 32173397)
36. Gjedde A, Johannsen P, Cold GE, Ostergaard L. Cerebral metabolic response to low blood flow: possible role of cytochrome oxidase inhibition. J Cereb Blood Flow Metab. 2005;25:1183-96. (Pubitemid 41710743)
37. Godoy DA, Biestro A, Puppo C. Does indomethacin cause cerebral ischemia? Acta Anaesthesiol Scand. 2005;49:1577-8. (Pubitemid 41565050)
38. Schumann P, Touzani O, Young AR, Verard L, Morello R, MacKenzie ET. Effects of indomethacin on cerebral blood flow and oxygen metabolism: a positron emission tomographic investigation in the anaesthetized baboon. Neurosci Lett. 1996;220:137-41. (Pubitemid 26426603)
39. St Lawrence KS, Ye FQ, Lewis BK, Frank JA, McLaughlin AC. Measuring the effects of indomethacin on changes in cerebral oxidative metabolism and cerebral blood flow during sensorimotor activation. Magn Reson Med. 2003;50:99-106. (Pubitemid 36841865)
40. Ling GS, Neal CJ. Maintaining cerebral perfusion pressure is a worthy clinical goal. Neurocrit Care. 2005;2:75-81. (Pubitemid 40404632)
41. 2) in focal lesions. Acta Neurochirurgica Supplement. 1998;71:162-5.
42. Marin-Caballos AJ, Murillo-Cabezas F, Cayuela-Dominguez A, et al. Cerebral perfusion pressure and risk of brain hypoxia in severe head injury: a prospective observational study. Crit Care. 2005;9:R670-6.
43. Johnston AJ, Steiner LA, Coles JP, et al. Effect of cerebral perfusion pressure augmentation on regional oxygenation and metabolism after head injury. Crit Care Med. 2005;33:189-95 discussion 255-7.
44. Rosner MJ, Rosner SD, Johnson AH. Cerebral perfusion pressure: management protocol and clinical results. J Neurosurg. 1995;83: 949-62. (Pubitemid 26048132)
45. Nelson DW, Thornquist B, MacCallum RM, et al. Analyses of cerebral microdialysis in patients with traumatic brain injury: relations to intracranial pressure, cerebral perfusion pressure and catheter placement. BMC Med. 2011;9:21.
46. Tofteng F, Larsen FS. The effect of indomethacin on intracranial pressure, cerebral perfusion and extracellular lactate and glutamate concentrations in patients with fulminant hepatic failure. J Cereb Blood Flow Metab. 2004;24:798-804. (Pubitemid 38880225)
47. Cooper DJ, Rosenfeld JV, Murray L, et al. Decompressive craniectomy in diffuse traumatic brain injury. N Engl J Med. 2011;364:1493-502.
48. Kamel H, Navi BB, Nakagawa K, Hemphill JC 3rd, Ko NU. Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials. Crit Care Med. 2011;39:554-9.